Use of nonmydriatic spectral-domain optical coherence tomography for diagnosing and treating diabetic macular edema

Use of nonmydriatic spectral-domain optical coherence tomography for diagnosing and treating diabetic macular edema - Use of nonmydriatic OCT for diagnosing and treating diabetic macular edema

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007536

Enrollment

Registered

2012-03-20

Start date

2012-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic retinopathy

Interventions

mensuration of central retinal thickness and reinal nerve fiber thickness by SD OCT instruments before and after pupil dilation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Male or female patients with diabetis mellitus type 1 or 2 who meet the WHO or ADA creteria for diabetes Without medical examination within 1 year Adequate pupil dilatation and clear media to perform digital photography and OCT scans

Exclusion criteria

Exclusion criteria: Recent (last 6 months) or ongoing poor glycaemic control (HbA1c greater than 10.0mg/dl) Uncontrolled hypertension (BP greater than 180/110mmHg) Any previous surgical or laser treatment to the study eye

Design outcomes

Primary

Measure	Time frame
visual acuity,intraocular pressure,macular thickness and retinal nerve fiber thickness (before and after mydriasis)	—

Secondary

Measure	Time frame
subjective symptom	—

Countries

Japan

Contacts

Public ContactTakao Hirano

Shinshu university school of medicine department of ophthalmology

takaoh@shinshu-u.ac.jp+81-263-37-2664

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026